Evidence map›Paper›PMID 42179160›Full record

ArticleBioinformatics (Oxford, England)2026

Representation learning for multi-modal spatially resolved transcriptomics data.

Kalin Nonchev, Sonali Andani, Joanna Ficek-Pascual, Marta Nowak, Bettina Sobottka, Tumor Profiler Consortium, Viktor H Koelzer, Gunnar Rätsch

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kalin NonchevDepartment of Computer Science, ETH Zurich, Universitätstrasse 6, Zurich 8092, Switzerland.ORCID 0009-0001-4904-8772
Sonali AndaniDepartment of Computer Science, ETH Zurich, Universitätstrasse 6, Zurich 8092, Switzerland.
Joanna Ficek-PascualDepartment of Computer Science, ETH Zurich, Universitätstrasse 6, Zurich 8092, Switzerland.
Marta NowakComputational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zürich, Schmelzbergstrasse 12, Zurich 8091, Switzerland.
Bettina SobottkaComputational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zürich, Schmelzbergstrasse 12, Zurich 8091, Switzerland.
Tumor Profiler Consortium
Viktor H KoelzerComputational and Translational Pathology Group, Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zürich, Schmelzbergstrasse 12, Zurich 8091, Switzerland.
Gunnar RätschDepartment of Computer Science, ETH Zurich, Universitätstrasse 6, Zurich 8092, Switzerland.ORCID 0000-0001-5486-8532

Funding

ETH core fundingETH ZurichHoffmann-La Roche Ltd.Promedica Foundation F-87701-41-01Swiss Federal Institutes of Technology strategic focus 2021-367Swiss National Science Foundation 201656Swiss National Science Foundation 220127Tumor Profiler Initiative and the Tumor Profiler CenterUniversity Hospital BaselUniversity Hospital ZurichUniversity of Zurich
6 · The paper itself

Abstract

motivationSpatial transcriptomics enables in-depth molecular characterization of samples on a morphology and RNA level while preserving spatial location. Integrating the resulting multi-modal data is an unsolved problem, and developing new solutions in precision medicine depends on improved methodologies.

resultsWe introduce AESTETIK, a convolutional deep learning model that jointly integrates spatial, transcriptomics, and morphology information to learn accurate spot representations. AESTETIK yielded substantially improved cluster assignments on widely adopted technology platforms (e.g. 10x Genomics™, NanoString™) across multiple datasets. We achieved performance enhancement on structured tissues (e.g. brain) with a 21% increase in median ARI over previous state-of-the-art methods. Notably, AESTETIK also demonstrated superior performance on cancer tissues with heterogeneous cell populations, showing a 2-fold increase in breast cancer, 79% in melanoma, and 21% in liver cancer. We expect that these advances will enable a multi-modal understanding of key biological processes. AVAILABILITY AND IMPLEMENTATION: AESTETIK is implemented in Python 3 and is available as open source software at http://www.github.com/ratschlab/aestetik. The Snakemake pipeline for reproducing the results is available at http://www.github.com/ratschlab/st-rep.

Indexed as

Deep LearningGene Expression ProfilingTranscriptomeHumansRepresentation Machine LearningSoftwareSpatial Transcriptomics

Identifiers

PMID42179160
PMCPMC13371760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.